Reaction
Restrictive Cardiomyopathy reporting signals
As of the last recalculation, Restrictive Cardiomyopathy appears in 302 FAERS reports alongside 15 co-occurring drug terms. The strongest observed disproportionality signal is PHYTONADIONE (PRR 92.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Phytonadione | 11 | 92.7 | 92.8 |
| Mesna Injection | 10 | 86.2 | 86.3 |
| Atropine | 10 | 86.0 | 86.1 |
| Mesna | 10 | 84.6 | 84.7 |
| Granisetron Hydrochloride | 11 | 75.3 | 75.4 |
| Granisetron | 11 | 75.0 | 75.0 |
| Atropine Sulfate | 10 | 65.9 | 66.0 |
| Tobramycin Solution | 10 | 59.3 | 59.4 |
| Tobramycin Sulfate | 10 | 57.5 | 57.6 |
| Heparin Sodium | 11 | 57.2 | 57.2 |
| Palivizumab | 10 | 46.4 | 46.4 |
| Busulfan | 10 | 45.3 | 45.3 |
| Alteplase | 9 | 42.6 | 42.6 |
| Tafamidis | 5 | 29.7 | 29.7 |
| Tobramycin | 10 | 29.6 | 29.6 |